Why Progenics Is Poised to Plunge

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Progenics Pharmaceuticals (NASDAQ: PGNX  ) has received a distressing two-star ranking.

With that in mind, let's take a closer look at Progenics and see what CAPS investors are saying about the stock right now.

Progenics facts

Headquarters (founded)

Tarrytown, N.Y. (1986)

Market Cap

$245.9 million

Industry

Biotechnology

Trailing-12-Month Revenue

$14.1 million

Management

CEO Mark Baker (since 2011)
CFO Angelo Lovallo Jr. (since 2011)

Trailing-12-Month Return on Equity

(42.7%)

Cash/Debt

$55.3 million / $0

Competitors

Dendreon
Nektar Therapeutics

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 10% of the 187 members who have rated Progenics believe the stock will underperform the S&P 500 going forward.

One of those Fools, All-Star zzlangerhans, tapped yesterday's huge surge as particularly unsustainable:

Progenics is a highly volatile stock at the moment, which makes it a great stock for skilled swing traders and a terrible stock for the unskilled ones. [T]he stock is up ... with no specific catalyst other than [Monday's] ho-hum press release regarding prostate cancer imaging agents acquired from failed biopharma outfit Molecular Insight. There's no good reason for the price spike to have occurred, let alone be sustained, which means it probably will be. Meanwhile, as I've stated many times previously, the long-term prospects of the company are bad as Relistor is a dead end and PSMA has been the light at the end of the tunnel for six years and counting.

While you can certainly make quick gains in hot biotech plays, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2485177, ~/Articles/ArticleHandler.aspx, 11/27/2014 8:28:06 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement